Journal articleLancet2016
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
- Journal
- Lancet
- Published
- 29 November 2015
- Citations
- 936
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 7
- Builds on itStudy of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer NCT01494506↗
- BackgroundNH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer NCT07314385↗
- BackgroundStereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer NCT07173387↗
- BackgroundTripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers NCT06135896↗
- BackgroundSurvival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry… NCT04984174↗
- BackgroundLiposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma NCT04662112↗
- BackgroundTAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma NCT04923529↗